ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2022

Aug 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2022-08-12

Reporting Person: Militello John (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-12	Restricted Stock Units	$	A	14310	Acquired		Common Stock (14310)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2: The restricted stock units will become fully vested on August 12, 2025.